Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

299 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma.
Perez-de-Llano L, Scelo G, Canonica GW, Chen W, Henley W, Larenas-Linnemann D, Peters MJ, Pfeffer PE, Tran TN, Ulrik CS, Popov TA, Sadatsafavi M, Hew M, Máspero J, Gibson PG, Christoff GC, Fitzgerald JM, Torres-Duque CA, Porsbjerg CM, Papadopoulos NG, Papaioannou AI, Heffler E, Iwanaga T, Al-Ahmad M, Kuna P, Fonseca JA, Al-Lehebi R, Rhee CK, Koh MS, Cosio BG, Perng Steve DW, Mahboub B, Menzies-Gow AN, Jackson DJ, Busby J, Heaney LG, Patel PH, Wang E, Wechsler ME, Altraja A, Lehtimäki L, Bourdin A, Bjermer L, Bulathsinhala L, Carter V, Murray R, Beastall A, Denton E, Price DB. Perez-de-Llano L, et al. Among authors: henley w. Ann Allergy Asthma Immunol. 2024 May;132(5):610-622.e7. doi: 10.1016/j.anai.2023.12.023. Epub 2023 Dec 25. Ann Allergy Asthma Immunol. 2024. PMID: 38151100 Free article.
Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS.
Price D, Henley W, Cançado JED, Fabbri LM, Kerstjens HAM, Papi A, Roche N, Şen E, Singh D, Vogelmeier CF, Nudo E, Carter V, Skinner D, Vella R, Soriano JB, Kots M, Georges G. Price D, et al. Among authors: henley w. Pragmat Obs Res. 2024 Jan 20;15:1-16. doi: 10.2147/POR.S438031. eCollection 2024. Pragmat Obs Res. 2024. PMID: 38274639 Free PMC article.
Efficacy and tolerability of Brivaracetam in people with intellectual disability compared to those without intellectual disability.
Allard J, Henley W, Sellers A, O'Shaughnessy E, Thomson O, McLean B, Parrett M, Rajakulendran S, Watkins L, Maguire M, Ellawela S, Tittensor P, Sen A, Mohanraj R, Bagary M, Ram S, Brown A, Shankar R. Allard J, et al. Among authors: henley w. Epilepsy Behav. 2024 Sep;158:109906. doi: 10.1016/j.yebeh.2024.109906. Epub 2024 Jun 26. Epilepsy Behav. 2024. PMID: 38936308 Free article.
Efficacy and tolerability of levetiracetam in people with and without intellectual disabilities: A naturalistic case control study.
Allard J, Sellers A, Henley W, McLean B, Parrett M, Rajakulendran S, Watkins L, Maguire M, Ellawela S, Tittensor P, Bransgrove J, Sen A, Mohanraj R, Bagary M, Ram S, Vernon N, Baldwin S, Gill J, Shankar R. Allard J, et al. Among authors: henley w. Seizure. 2024 Aug;120:25-32. doi: 10.1016/j.seizure.2024.05.010. Epub 2024 May 16. Seizure. 2024. PMID: 38897161 Free article.
Impact of the iWHELD digital person-centered care program on quality of life, agitation and psychotropic medications in people with dementia living in nursing homes during the COVID-19 pandemic: A randomized controlled trial.
McDermid J, Henley W, Corbett A, Williams G, Fossey J, Clare L, Fox C, Aarsland D, Khan Z, Soto M, Woodward-Carlton B, Cook EM, Cummings J, Sweetnam A, Chan X, Lawrence M, Ballard C; iWHELD study group. McDermid J, et al. Among authors: henley w. Alzheimers Dement. 2024 Mar;20(3):1797-1806. doi: 10.1002/alz.13582. Epub 2023 Dec 20. Alzheimers Dement. 2024. PMID: 38116916 Free PMC article. Clinical Trial.
299 results